HomeFilePharmacology

Pharmacology

View Category

Antiplatelet

Dual antiplatelet therapy discontinuation causes more thrombotic events at 12 months

Several randomized studies have shown that dual antiplatelet therapy (DAPT) is as effective to prevent thrombotic events in...
solaci -
Learn More
Day 2

SOLACI 2017 | BRS: Present & Future

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Stephen...
solaci -
Learn More
Day 2

SOLACI CACI 2017 | BRS: Presente y Futuro

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Stephen...
solaci -
Learn More
Day 2

SOLACI CACI 2017 | BRS at the crossroad: technological development to reduce complications

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Patrick...
solaci -
Learn More
Antiplatelet

Post DES Dual Antiplatelet Therapy Still under Debate

The NIPPON trial (Nobori Dual Antiplatelet Therapy as Appropriate Duration) was a randomized study comparing a short dual...
solaci -
Learn More
Acute coronary syndromes

Transradial access shows no benefit of bivalirudin

The aim of this study was to compare bivalirudin against heparin in patients with ST elevation acute...
solaci -
Learn More
Other

Are 7 Fr Dedicated Transradial Introducers Safe?

Courtesy of Dr. Carlos Fava. The transradial approach has been proven beneficial for quite some time now, but certain...
solaci -
Learn More
Antiplatelet

ARTE: Aspirin or Aspirin and Clopidogrel after TAVR?

Courtesy of SBHCI. This study presented at Euro PCR and simultaneously published by JACC Cardiovascular Interventions poses a...
solaci -
Learn More